Arena Pharmaceuticals, Inc. Other Operating Activities, Cash Flow Statement
Arena Pharmaceuticals, Inc. reported Other Operating Activities, Cash Flow Statement of $6.62 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2022-02-23
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for the quarter ending 2021-12-31 was $1.84M, a 18.53% increase year-over-year.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for the quarter ending 2021-09-30 was $1.50M.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for the quarter ending 2021-06-30 was $1.62M.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for the quarter ending 2021-03-31 was $1.66M, a 7440.91% increase year-over-year.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for fiscal 2021 was $6.62M, a 777.32% increase from fiscal 2020.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for fiscal 2020 was $754.00K, a 80.89% decline from fiscal 2019.
- Arena Pharmaceuticals, Inc. other operating activities, cash flow statement for fiscal 2019 was $3.95M.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.34M derived: sum of 2 quarters · filed 2022-02-23 | $4.96M derived: sum of 3 quarters · filed 2022-02-23 | $6.62M 10-K · filed 2022-02-23 |
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.11M derived: sum of 2 quarters · filed 2021-11-04 | $4.77M 10-Q · filed 2021-11-04 | $6.33M derived: sum of 4 quarters · filed 2022-02-23 |
| 2021-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.28M 10-Q · filed 2021-08-05 | $4.83M derived: sum of 3 quarters · filed 2022-02-23 | $4.63M derived: sum of 4 quarters · filed 2022-02-23 |
| 2021-03-31 | $1.66M 10-Q · filed 2021-05-05 | $3.21M derived: sum of 2 quarters · filed 2022-02-23 | $3.02M derived: sum of 3 quarters · filed 2022-02-23 | $2.39M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.36M derived: sum of 2 quarters · filed 2022-02-23 | $732.00K derived: sum of 3 quarters · filed 2022-02-23 | $754.00K 10-K · filed 2022-02-23 |
| 2020-09-30 | -$198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$822.00K derived: sum of 2 quarters · filed 2021-11-04 | -$800.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$624.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$602.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $3.95M 10-K · filed 2022-02-23 |